Brain-derived neurotrophic factor (BDNF), a key regulator of synaptic plasticity and neurogenesis, has also been examined, with lower circulating levels associated with worse cognitive outcomes and depression in certain cancer cohorts [23, 24]. Here, BDNF is linked to depressive symptom measurement.